Radioactive iodine (RAI) treatment was associated with an increased risk of developing Graves' orbitopathy (GO) in patients with thyroid cancer. Patients who developed GO received significantly higher ...

Initial thyroid-stimulating immunoglobulin (TSI) levels and early initiation of treatment were found to predict TSI normalization in a recent study published in BMC Ophthalmology by Park and ...

SAN DIEGO — Double vision is the predominant symptom in more than half of patients with moderate to severe Graves' orbitopathy; however, the symptom negatively correlates with inflammation and in fact ...

First, many patients with even mild Graves' orbitopathy have a substantial decrease in their quality of life, as assessed either by general health–related quality-of-life questionnaires 3 or by a ...

For sight-threatening thyroid eye disease (TED), both the European Group on Graves’ Orbitopathy guidelines and the American Thyroid Association and the European Thyroid Association (ATA/ETA) statement ...

A collaborative program designed to treat thyroid eye disease (TED) at the University of Utah offers patients access to highly customized treatments—including a delicate endoscopic surgery at the John ...

Thyroid eye disease (TED), also known as Graves’ eye disease, usually stems from an autoimmune condition that starts when immune cells attack the thyroid gland, a tiny butterfly-shaped gland at the ...

Graves’ disease is the most common cause of hyperthyroid­ism and frequently causes changes to the eye and surrounding structures, including retraction of the eyelid, bulging of the eye, and restricted ...

According to a new study, smoking has been found to be associated with increased autoimmune activity, higher risk of ...

Ocular surface discomfort is the most common chronic complaint in thyroid eye disease (TED) and stems from exposure, tear instability and hyper‑osmolarity caused by proptosis and eyelid retraction.